Stability and Blood Level Determinations of Cefaclor, a New Oral Cephalosporin Antibiotic
AUTOR(ES)
Foglesong, M. A.
RESUMO
Cefaclor solutions in pH 2.5 and 4.5 buffers contained at least 90% of their initial activity after 72 h at 4°C. Samples in pH 6.0, 7.0, and 8.0 buffers contained 70, 46, and 34%, respectively, of their initial activity after 72 h at 4°C. After 72 h at 25°C, samples prepared with pH 2.5, 4.5, 6.0, 7.0, and 8.0 buffers contained 95, 69, 16, 5, and 3%, respectively, of their initial activity. After 72 h at 37°C, cefaclor solutions in pH 2.5 buffer contained 80% of the initial activity, whereas samples prepared in pH 4.5, 6.0, 7.0, and 8.0 buffers contained less than 20%. Laboratory-prepared plasma and serum samples showed an 8% loss in activity when incubated for 6 h at 4°C, a 51% loss when incubated for 6 h at 25°C, and a 48% loss when incubated for 2 h at 37°C. Clinical samples demonstrated a similar stability pattern. Degradation rates for cefaclor in commercially prepared serum increased from 4- to 10-fold in comparison to rates obtained when samples were made in human serum freshly prepared in our laboratory. Consequently, serum standards should be made in freshly prepared human serum.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=352183Documentos Relacionados
- In Vitro Studies with Cefaclor, a New Oral Cephalosporin
- In Vitro Activity of Cefaclor, a New Orally Administered Cephalosporin Antibiotic
- Comparison of In Vitro Antibacterial Activity of Three Oral Cephalosporins: Cefaclor, Cephalexin, and Cephradine
- Comparative in vitro activity and beta-lactamase stability of FK482, a new oral cephalosporin.
- Antimicrobial activity and stability to beta-lactamase of BMY-28271, a new oral cephalosporin ester.